Cost Analysis of Paroxetine versus Imipramine in Major Depression
- 1 September 1995
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 8 (3) , 223-232
- https://doi.org/10.2165/00019053-199508030-00005
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Indirect Costs in Economic StudiesPharmacoEconomics, 1993
- Disability and Depression Among High Utilizers of Health CareArchives of General Psychiatry, 1992
- Principles of Pharmacoeconomic Analysis of Drug TherapyPharmacoEconomics, 1992
- A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patientsThe British Journal of Psychiatry, 1991
- CitalopramDrugs, 1991
- ParoxetineDrugs, 1991
- Three-Year Outcomes for Maintenance Therapies in Recurrent DepressionArchives of General Psychiatry, 1990
- One-Month Prevalence of Mental Disorders in the United StatesArchives of General Psychiatry, 1988
- The economic burden of depressionGeneral Hospital Psychiatry, 1986
- NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development PanelAmerican Journal of Psychiatry, 1985